Imaging and Treatment Planning for Cardiac Radioablation

Launched by STEWART GAEDE · Apr 14, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Imaging and Treatment Planning for Cardiac Radioablation," is focused on improving treatment for patients with a specific heart condition called monomorphic ventricular tachycardia (VT). The study aims to find out if a type of imaging called computed tomography (CT) can identify areas of heart damage (known as ischemic scar) just as well as another imaging method called MRI. Additionally, the trial will explore the best ways to deliver a treatment called cardiac radioablation, which uses radiation to target these damaged areas in the heart, while minimizing any movement caused by breathing during the procedure.

To participate in this study, individuals must be 18 years or older and have ischemic cardiomyopathy with monomorphic VT, and they need to be referred by a cardiologist. Participants will have two imaging sessions: one with CT scans and another with MRI scans. These sessions will help researchers compare the results and ensure that the treatment plans are safe and effective. It's important to note that some individuals may not be eligible, such as those with certain heart rhythms, pregnant women, or those with specific health conditions. The trial is not yet recruiting participants, but it aims to provide valuable insights into improving heart treatment in the future.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• • Ischemic cardiomyopathy with monomorphic VT
• • Referred by cardiologists
• • 18 years of age or older Exclusion Criteria
• • Polymorphic ventricular tachycardia
• • Ventricular fibrillation
• • Pregnant or breastfeeding or planning to become pregnant or breastfeed during the study
• • Estimated glomerular filtration rate ≤ 30 mL/min/1.73m2
• • Unable to undergo MRI due to metal implants
• • Previous allergic reaction to CT contrast agent